Oxford University
19 Jan 2021
Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.
17 Jan 2021
On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.
10 Jan 2021
The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.
08 Jan 2021
India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).
07 Jan 2021
The central government has prepared a detailed draft for the transport of vaccines across India ahead of a nationwide roll-out.
07 Jan 2021
A dry run of the COVID-19 vaccine roll-out was conducted in Haryana on Thursday, a day before the exercise will be conducted across India.
05 Jan 2021
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
04 Jan 2021
Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.
03 Jan 2021
Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.
03 Jan 2021
Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.
03 Jan 2021
Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.
03 Jan 2021
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
31 Dec 2020
The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.
30 Dec 2020
The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.
28 Dec 2020
The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.
28 Dec 2020
The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.
26 Dec 2020
Labeled as a coronavirus hotspot once, Dharavi, believed to be the largest slum in Asia, reported no new coronavirus cases on Friday since April 1 when the first infection came to light.
22 Dec 2020
Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.
18 Dec 2020
India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.
09 Dec 2020
The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.
08 Dec 2020
India may license some COVID-19 vaccines in the next few weeks, the Union Health Ministry said on Tuesday.
08 Dec 2020
A 90-year-old woman in the United Kingdom has become the world's first person to receive the COVID-19 vaccine developed by Pfizer and BioNTech outside of clinical trials.
02 Dec 2020
With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.
01 Dec 2020
The Serum Institute of India (SII) on Tuesday said that its COVID-19 vaccine candidate was "safe and immunogenic," in response to allegations that a trial participant developed serious side-effects after being administered the dose.
30 Nov 2020
The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.
28 Nov 2020
The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.
28 Nov 2020
Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.
24 Nov 2020
The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.
23 Nov 2020
The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.
23 Nov 2020
The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.
20 Nov 2020
Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.
19 Nov 2020
India's Health Minister Dr. Harsh Vardhan said today that deliveries of coronavirus vaccine will happen within a few months, adding that the country's scientists are way ahead in terms of research.
16 Nov 2020
American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.
16 Nov 2020
It has been a great rewind for the fans of Claire Foy, the actor who played the role of Queen Elizabeth II in the first two seasons of Netflix British empire drama The Crown.
14 Nov 2020
The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.
12 Nov 2020
The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.
29 Oct 2020
In a welcome piece of development, Serum Institute of India's CEO Adar Poonawalla said on Wednesday that the coronavirus vaccine, being developed by Oxford University, could be available for use in India by December 2020.
26 Oct 2020
The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.
22 Oct 2020
A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.
20 Oct 2020
As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.
